Researchers believe GIP co-activation may have a protective effect on the GI tract, explaining why dual and triple agonists are often better tolerated than single-agonist Semaglutide (which has 44% nausea rates)
Everything in medicine is a risk-benefit ratio, says Florencia Halperin, MD, chief medical officer at Form Health, a virtual medical weight-loss clinic based in Boston
GLP-1 receptor agonists represent a major shift away from traditional mechanical devices
Incretins are gut hormones released after eating that stimulate insulin secretion and influence appetite regulation
As your treatment progresses, our team will monitor your progress and increase the dose to optimize appetite suppression and support your weight loss goals
GIP receptor: Boosts meal-stimulated insulin and can influence fat storage, affecting how the body handles calories